BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6123474)

  • 1. [Interactions between buprenorphine, narcotic analgesic, and centrally acting drugs in prolongation of halothane-induced sleeping and analgesia (author's transl)].
    Yasuda Y; Shioya Y; Nakai S; Shintani S; Hiyama T
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):163-72. PubMed ID: 6123474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analgesic and narcotic antagonist effects of buprenorphine (author's transl)].
    Hiyama T; Shintani S; Tsutsui M; Yasuda Y
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):147-62. PubMed ID: 7084817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroencephalographic study of pentazocine and buprenorphine.
    Kubicki S; Azcona A
    Acta Anaesthesiol Belg; 1979; 30 Suppl():123-33. PubMed ID: 547656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modification of the analgetic effects (buprenorphine, pentazocine, pethidine) on respiration and haemodynamics by epidural, halothane- or neuroleptanaesthesia (author's transl)].
    Wüst HJ; Moritz KG; Sandmann W; Richter O
    Anasth Intensivther Notfallmed; 1980 Apr; 15(2):119-34. PubMed ID: 7396100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B; Christoph T; Strassburger W; Friderichs E
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central action of narcotic analgesics. V. Participation of serotonin in the mechanism of action of narcotic analgesics.
    Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1979; 31(5):461-71. PubMed ID: 44745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between narcotic analgesics and benzodiazepine derivatives on behavior in the mouse.
    Shannon HE; Holtzman SG; Davis DC
    J Pharmacol Exp Ther; 1976 Nov; 199(2):389-99. PubMed ID: 10428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of histamine receptor antagonists on antinociceptive action of narcotic analgesics.
    Malec D
    Pol J Pharmacol Pharm; 1987; 39(3):229-35. PubMed ID: 2894018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of multiple analgesic opiate receptors.
    Fürst S; Knoll J
    Int J Tissue React; 1985; 7(1):69-77. PubMed ID: 2861170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of an endogenous compound 1-methyl-1,2,3,4,-tetrahydroisoquinoline on morphine-induced analgesia, dependence and neurochemical changes in dopamine metabolism in rat brain structures.
    Wasik A; Romańska I; Antkiewicz-Michaluk L
    J Physiol Pharmacol; 2007 Jun; 58(2):235-52. PubMed ID: 17622694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of the analgesic efficacy and potency of pentazocine by the D'Amour and Smith method.
    Gray WD; Osterberg AC; Scuto TJ
    J Pharmacol Exp Ther; 1970 Mar; 172(1):154-62. PubMed ID: 5416940
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of butorphanol and its metabolites on the levels of monoamines and their metabolites in the rat brain.
    Niwa M; Nose T; Nozaki M; Tsurumi K; Fujimura H
    Jpn J Pharmacol; 1985 Dec; 39(4):515-28. PubMed ID: 2419614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological properties of buprenorphine, a new analgesic agent. Part II. (author's transl)].
    Shintani S; Umezato M; Toba Y; Yamaji Y; Kitaura K; Tani T; Ishiyama H; Kikuchi T; Mori T; Nakai S; Watanabe K; Hiyama T
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):173-91. PubMed ID: 6123475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine-like discriminative stimulus effects of buprenorphine and demethoxybuprenorphine in rats: quantitative antagonism by naloxone.
    Shannon HE; Cone EJ; Gorodetzky CW
    J Pharmacol Exp Ther; 1984 Jun; 229(3):768-74. PubMed ID: 6547177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study about the analgesic effect of buprenorphine (author's transl)].
    Rigolot JC; Vergnes Y; Bouket JL; Gauthier-Lafaye P
    Anesth Analg (Paris); 1979; 36(7-8):317-21. PubMed ID: 525837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antinociceptive activity of flupirtine: a structurally new analgesic.
    Nickel B
    Postgrad Med J; 1987; 63 Suppl 3():19-28. PubMed ID: 2833734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central action of narcotic analgesics. I. Catalepsy and stereotypy in rats and narcotic analgesics.
    Malec D; Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1977; 29(3):177-93. PubMed ID: 560683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological actions of eptazocine (l-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1,H-4-benzazonine). 4. Antagonistic action of naloxone on eptazocine analgesia].
    Nabeshima T; Yamada S; Yamaguchi K; Matsuno K; Kameyama T; Sakakibara S; Matsumoto S
    Nihon Yakurigaku Zasshi; 1983 May; 81(5):411-20. PubMed ID: 6629212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.